The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke

BACKGROUND: Intravenous recombinant tissue plasminogen activator (rt-PA) is approved for use in selected patients with ischaemic stroke within 3 hours of symptom onset. IST-3 seeks to determine whether a wider range of patients may benefit. DESIGN: International, multi-centre, prospective, randomize...

Full description

Saved in:
Bibliographic Details
Main Authors: Sandercock, Peter, Lindley, Richard, Wardlaw, Joanna, Dennis, Martin, Lewis, Steff, Venables, Graham, Kobayashi, Adam, Czlonkowska, Anna, Berge, Eivind, Slot, Karsten Bruins, Murray, Veronica, Peeters, Andre, Hankey, Graeme, Matz, Karl, Brainin, Michael, Ricci, Stefano, Celani, Maria Grazia, Righetti, Enrico, Cantisani, Teresa, Gubitz, Gord, Phillips, Steve, Arauz, Antonio, Prasad, Kameshwar, Correia, Manuel, Lyrer, Phillippe
Format: Artigo
Language:Inglês
Published: BioMed Central 2008
Subjects:
Study Protocol
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2442584/
https://ncbi.nlm.nih.gov/pubmed/18559104
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-9-37
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items